Parkinson’s Disease Raises Risk of Hip Surgery Complications

Patients living with Parkinson’s disease face a significantly elevated risk of returning to the hospital and undergoing additional surgical procedures in the weeks following a total hip replacement, according to a new study published in Scientific Reports. The research, conducted by a team of researchers from the Technion Israel Institute of Technology and Carmel Medical Center, provides critical national data on the short-term outcomes of elective primary total hip arthroplasty in this specific population. By analyzing a large retrospective cohort, the study highlights that the neuromuscular dysfunction and medical frailty often associated with Parkinson’s disease can complicate the recovery process, leading to higher rates of readmission and procedural escalation within the first 90 days after surgery.

The study utilized the Nationwide Readmissions Database, a comprehensive dataset covering hospital admissions from 2020 to 2022, to identify adult patients who underwent elective primary total hip arthroplasty on the day of their hospital admission. The researchers constructed a variable-ratio propensity score-matched cohort to ensure a fair comparison between patients with Parkinson’s disease and those without. This methodological approach allowed the team to match patients based on demographics, payer status, hospital characteristics, calendar year, and existing comorbidities, ensuring that the groups were comparable in all aspects except for the presence of Parkinson’s disease. The final matched cohort included 12,143 elective primary hip replacements, with 2,043 patients diagnosed with Parkinson’s disease and 10,100 control patients without the condition.

The findings reveal that patients with Parkinson’s disease experienced higher rates of perioperative complications compared to their counterparts without the disease. Specifically, the study identified increased incidences of blood transfusion, pneumonia, urinary tract infections, and hip dislocation among the Parkinson’s group. All of these complications showed statistically significant differences, with p-values of 0.015 or lower. Despite these elevated complication rates, the researchers noted that in-hospital mortality remained low and was similar between the two groups, suggesting that while the risk of complications is higher, the immediate life-threatening risk during the initial hospital stay does not differ significantly.

Perhaps the most striking finding of the study concerns the post-discharge period. Within 90 days of the initial surgery, patients with Parkinson’s disease had a substantially higher rate of readmission to the hospital. The readmission rate for the Parkinson’s group was 10.3%, compared to just 5.8% for the control group. This difference was statistically significant, with an odds ratio of 1.86 and a p-value of less than 0.001. This indicates that patients with Parkinson’s disease are nearly twice as likely to require hospital readmission in the critical postoperative window, underscoring the need for enhanced surveillance and support after they leave the hospital.

Furthermore, the study found that the readmissions among Parkinson’s patients were often associated with procedural escalation, meaning that the return to the hospital frequently resulted in additional surgical interventions. The rate of reoperation, which involves any surgical procedure performed after the initial hip replacement, was 3.3% in the Parkinson’s group compared to 0.9% in the control group. Similarly, the rate of revision surgery, which involves replacing or adjusting the prosthetic components, was 3.0% for Parkinson’s patients versus 0.7% for controls. Both of these outcomes were statistically significant with p-values of less than 0.001, highlighting a clear trend toward more invasive follow-up care for patients with Parkinson’s disease.

The length of stay in the hospital was also longer for patients with Parkinson’s disease, reflecting the more complex nature of their postoperative care. However, the study found no significant difference in hospital charges between the two groups. This suggests that while the clinical course is more complicated for Parkinson’s patients, the financial burden on the healthcare system may not be disproportionately higher in terms of direct hospital costs, although the broader societal costs of readmission and additional surgery are likely to be substantial.

The authors suggest that the increased vulnerability of Parkinson’s patients may be due to a combination of factors, including the neuromuscular dysfunction inherent to the disease, which can affect balance and mobility, and the general medical frailty that often accompanies chronic neurological conditions. These factors can make the recovery process more challenging and increase the risk of complications such as falls, infections, and dislocations. The study emphasizes the importance of perioperative optimization, which involves preparing patients thoroughly before surgery to minimize risks, and postoperative surveillance, which involves closely monitoring patients after they leave the hospital to detect and address complications early.

This research contributes to the growing body of evidence that patients with neurological conditions require tailored care pathways when undergoing major orthopedic surgeries. The findings underscore the need for healthcare providers to be aware of the specific risks associated with Parkinson’s disease and to implement strategies to mitigate these risks. This may include enhanced preoperative assessments, specialized postoperative rehabilitation programs, and closer follow-up appointments to ensure that any complications are identified and managed promptly.

As the population ages and the prevalence of both Parkinson’s disease and hip osteoarthritis increases, the demand for total hip arthroplasty in patients with neurological comorbidities is likely to rise. This study provides valuable insights that can inform clinical guidelines and improve patient outcomes. By highlighting the increased risk of readmission and reoperation, the researchers aim to raise awareness among clinicians and patients alike, fostering a more proactive approach to postoperative care. Ultimately, the goal is to ensure that patients with Parkinson’s disease can benefit from the life-changing advantages of hip replacement surgery while minimizing the risks associated with their underlying condition.

Subject of Research: Parkinson’s disease is associated with increased 90-day readmission and reoperation after elective total hip arthroplasty

Article Title: Parkinson’s disease is associated with increased 90-day readmission and reoperation after elective total hip arthroplasty

Article References: Maman, D., Steinfeld, Y., & Berkovich, Y. (2026). Parkinson’s disease is associated with increased 90-day readmission and reoperation after elective total hip arthroplasty. Scientific Reports. https://doi.org/10.1038/s41598-026-77025-3

Image Credits: AI Generated

DOI: 10.1038/s41598-026-77025-3

Keywords: Parkinson, disease, associated, increased, readmission, reoperation, elective, total, arthroplasty, scientific research